Overall rank by patents
#5,399
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
SIO2 Medical Products, Llc
USPTO PatentsView assignee record — 64 granted patents across 28 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
64
Total patents granted
28
CPC technology areas
18.6
Avg claims per patent
+37%
5-year filing velocity
The verdict
SIO2 holds 64 US patents across 28 technology areas — rank #5,399 of 50,000 tracked assignees.
- #5,399
- of 50,000 US assignees by volume
- Top 16%
- by Innovation Score (48.6/100)
- 18.6
- avg claims per patent
- +37%
- filing velocity, last 5 yrs
Portfolio overview
SIO2 MEDICAL PRODUCTS, LLC has been granted 64 US utility patents between 2016 and 2025, placing SIO2 MEDICAL PRODUCTS, LLC at rank #5,399 across all assignees tracked by PlainPatent. This portfolio spans 28 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, SIO2 MEDICAL PRODUCTS, LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 27 in the 2015–2019 window — a +37% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SIO2 MEDICAL PRODUCTS, LLC's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 28 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SIO2 MEDICAL PRODUCTS, LLC against peers pursuing similar technology classes.
How does SIO2 compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- SIO2 Medical Prod… ◀ 64
SIO2 MEDICAL PRODUCTS, LLC
64 patents
What this shows SIO2 holds 64 patents — placing it at rank #5,399 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
SIO2's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2016–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 5 | 7.8% |
| 2017 | 6 | 9.4% |
| 2018 | 9 | 14.1% |
| 2019 | 7 | 10.9% |
| 2020 | 9 | 14.1% |
| 2021 | 9 | 14.1% |
| 2022 | 7 | 10.9% |
| 2023 | 6 | 9.4% |
| 2024 | 3 | 4.7% |
| 2025 | 3 | 4.7% |
Which technologies does SIO2 MEDICAL PRODUCTS, LLC patent most?
Top 15 of 28 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does SIO2 MEDICAL PRODUCTS, LLC hold?
SIO2 MEDICAL PRODUCTS, LLC holds 64 US granted patents filed between 2016 and 2025, spanning 28 technology areas.
What is SIO2 MEDICAL PRODUCTS, LLC's Innovation Score?
SIO2 MEDICAL PRODUCTS, LLC has an Innovation Score of 48.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does SIO2 MEDICAL PRODUCTS, LLC focus on?
SIO2 MEDICAL PRODUCTS, LLC's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 47 patents. The company has filed patents in 28 CPC subclasses total.
Is SIO2 MEDICAL PRODUCTS, LLC's patent filing rate increasing or decreasing?
SIO2 MEDICAL PRODUCTS, LLC's recent filing velocity is +37% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for SIO2 MEDICAL PRODUCTS, LLC's patents?
SIO2 MEDICAL PRODUCTS, LLC's patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the SIO2 MEDICAL PRODUCTS, LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
How to use this portfolio
SIO2's 64 grants land it in the top 16% by Innovation Score — but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance — SIO2 ranks #5,399 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M — see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
A61M technology
SIO2 MEDICAL PRODUCTS, LLC's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where SIO2 MEDICAL PRODUCTS, LLC ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov
